Goldfeld received her award at the 2025 NFID Awards Gala and Silent Auction in October in Washington, DC. Jie Yang, HMS ...

This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...

Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase ...

Five LMU researchers have been awarded Consolidator Grants by the European Research Council. Their projects deal with climate change, strokes, ...

Patients with previously incurable cancer are seeing incredible results thanks to a pioneering new treatment that has just ...

Second FDA designation for SENTI-202 this year, after Orphan Drug Designation, is supported by clinical data showing deep and durable complete remission rates combined with a well-tolerated safety ...

Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the stem cell-based therapy to treat severe aplastic ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high ...

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of ...

The 2025 Tata Transformation Prize Winners, selected from 212 entries from 27 Indian states by an international jury of leading experts, are: * Food Security Winner: Padubidri V. Shivaprasad, PhD, ...

A combination of two therapies, azacitidine and venetoclax, or aza-ven, outperformed intensive chemotherapy for acute myeloid leukemia in patients healthy enough to receive aggressive treatment, ...